Comparative associations between anticholinergic burden and emergency department visits for anticholinergic adverse events in older Korean adults: a nested case-control study using national claims data for validation of a novel country-specific scale

被引:7
作者
Hwang, Sunghee [1 ,2 ]
Chung, Jee Eun [1 ,2 ]
Jun, Kwanghee [3 ,4 ]
Ah, Young-Mi [5 ]
Kim, Kwang-Il [6 ]
Lee, Ju-Yeun [3 ,4 ]
机构
[1] Hanyang Univ, Coll Pharm, Ansan, Gyeonggi Do, South Korea
[2] Hanyang Univ, Inst Pharmaceut Sci & Technol, Ansan, Gyeonggi Do, South Korea
[3] Seoul Natl Univ, Coll Pharm, Seoul, South Korea
[4] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea
[5] Yeungnam Univ, Coll Pharm, Gyongsan, Gyeongsangbuk D, South Korea
[6] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seognam Si, Gyeonggi Do, South Korea
基金
新加坡国家研究基金会;
关键词
Anticholinergic syndromes; Cholinergic antagonists; Emergency medical services; Geriatrics;
D O I
10.1186/s40360-020-00467-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Considering the limited generalizability of previous anticholinergic burden scales, the Korean Anticholinergic Burden Scale (KABS) as a scale specific to the Korean population was developed. We aimed to validate the KABS by detecting the associations between high anticholinergic burden, measured with the KABS, and emergency department (ED) visits compared to the pre-existing validated scales in older Korean adults. Methods A nested case-control study was conducted using national claims data. The cases included the first anticholinergic ED visits between July 1 and December 31, 2016. Anticholinergic ED visits were defined as ED visits with a primary diagnosis of constipation, delirium, dizziness, fall, fracture, or urinary retention. Propensity score-matched controls were identified. Average daily AB scores during 30 days before the index date were measured. Multivariate logistic regression analyses were performed. Results In total, 461,034 were included. The highest proportion of those with high AB was identified with KABS (5.0%). Compared with those who had a KABS score of 0, older adults with a score >= 3 were at higher risk for overall anticholinergic ED visits (aOR, 1.62, 95% CI, 1.53-1.72), as well as visits for falls/fractures (aOR: 1.54, 95% CI: 1.40-1.69), dizziness (aOR: 1.44, 95% CI: 1.30-1.59), delirium (aOR: 2.96, 95% CI: 2.28-3.83), constipation (aOR: 1.84, 95% CI: 1.68-2.02), and urinary retention (aOR: 2.13, 95% CI: 1.79-2.55). High AB by KABS showed a stronger association with overall anticholinergic ED visits and visits due to delirium and urinary retention than those by other scales. Conclusions In conclusion, KABS is superior to pre-existing scales in identifying patients with high AB and predicting high AB-related ED visits in older Korean adults.
引用
收藏
页数:8
相关论文
共 27 条
  • [1] DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities
    Ailabouni, Nagham
    Mangin, Dee
    Nishtala, Prasad S.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 167 - 178
  • [2] Boustani M., 2008, Impact of anticholinergics on the aging brain: a review and practical application
  • [3] "How Much Will I get Charged for This?" Patient Charges for Top Ten Diagnoses in the Emergency Department
    Caldwell, Nolan
    Srebotnjak, Tanja
    Wang, Tiffany
    Hsia, Renee
    [J]. PLOS ONE, 2013, 8 (02):
  • [4] The anticholinergic drug scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity
    Carnahan, Ryan M.
    Lund, Brian C.
    Perry, Paul J.
    Pollock, Bruce G.
    Culp, Kennith R.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (12) : 1481 - 1486
  • [5] Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review
    Fox, Chris
    Smith, Toby
    Maidment, Ian
    Chan, Wei-Yee
    Bua, Nelson
    Myint, Phyo Kyaw
    Boustani, Malaz
    Kwok, Chun Shing
    Glover, Michelle
    Koopmans, Imogen
    Campbell, Noll
    [J]. AGE AND AGEING, 2014, 43 (05) : 604 - 615
  • [6] Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes
    Hsu, Wen-Han
    Wen, Yu-Wen
    Chen, Liang-Kung
    Hsiao, Fei-Yuan
    [J]. ANNALS OF FAMILY MEDICINE, 2017, 15 (06) : 561 - 569
  • [7] Impact of anticholinergic burden on emergency department visits among older adults in Korea: A national population cohort study
    Hwang, Sunghee
    Jun, Kwanghee
    Ah, Young-Mi
    Han, Euna
    Chung, Jee Eun
    Lee, Ju-Yeun
    [J]. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2019, 85
  • [8] Development of an Anticholinergic Burden Scale specific for Korean older adults
    Jun, Kwanghee
    Hwang, Sunghee
    Ah, Young-Mi
    Suh, Yewon
    Lee, Ju-Yeun
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2019, 19 (07) : 628 - 634
  • [9] A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples
    Kim, Logyoung
    Kim, Jee-Ae
    Kim, Sanghyun
    [J]. EPIDEMIOLOGY AND HEALTH, 2014, 36
  • [10] Anticholinergic Drug Use and Negative Outcomes Among the Frail Elderly Population Living in a Nursing Home
    Landi, Francesco
    Dell'Aquila, Giuseppina
    Collamati, Agnese
    Martone, Anna Maria
    Zuliani, Giovanni
    Gasperini, Beatrice
    Eusebi, Paolo
    Lattanzio, Fabrizia
    Cherubini, Antonio
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2014, 15 (11) : 825 - 829